PADA-1 Trial: ctDNA Monitoring for Acquired ESR1 Mutations in Advanced Breast Cancer
Drs Mayer and Kalinsky provide insights and offer their impressions of the PADA-1 trial, focusing on ESR1 mutation monitoring with circulating tumor DNA (ctDNA).
Breast Cancer Advanced Breast Hr Breast Cancer Hr Positive Breast Cancer Breast Cancer Treatment Esr1 Mutations
Source: onclive.com